Variant report
Variant | esv33557 |
---|---|
Chromosome Location | chr1:84236172-84236848 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:2)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:2 , 50 per page) page:
1
No data |
No data |
No data |
No data |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs543559672 | chr1:84236175-84236176 | Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
2 | rs534200730 | chr1:84236183-84236184 | Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
3 | rs554084030 | chr1:84236201-84236202 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs576759080 | chr1:84236285-84236286 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs545736514 | chr1:84236293-84236294 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs563651324 | chr1:84236294-84236295 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs76619778 | chr1:84236353-84236354 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs562352817 | chr1:84236367-84236368 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs7524397 | chr1:84236405-84236406 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
10 | rs10489500 | chr1:84236434-84236435 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
11 | rs190660951 | chr1:84236469-84236470 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs67983151 | chr1:84236471-84236472 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs113084792 | chr1:84236479-84236480 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs373186936 | chr1:84236493-84236494 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs527513903 | chr1:84236525-84236526 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs10489501 | chr1:84236543-84236544 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
17 | rs370829163 | chr1:84236545-84236546 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs17129344 | chr1:84236552-84236553 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
19 | rs533082635 | chr1:84236559-84236560 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs17129346 | chr1:84236574-84236575 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
21 | rs569175184 | chr1:84236582-84236583 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs1983637 | chr1:84236622-84236623 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
23 | rs75424080 | chr1:84236638-84236639 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs36017423 | chr1:84236639-84236640 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
25 | rs10489502 | chr1:84236661-84236662 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
26 | rs200047707 | chr1:84236672-84236673 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs181510010 | chr1:84236673-84236674 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs74094961 | chr1:84236705-84236706 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
29 | rs11807908 | chr1:84236714-84236715 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs200909198 | chr1:84236720-84236721 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs556093835 | chr1:84236721-84236722 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs375131482 | chr1:84236725-84236726 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs76196008 | chr1:84236727-84236728 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs575974428 | chr1:84236728-84236729 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs185458139 | chr1:84236746-84236747 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs549408830 | chr1:84236793-84236794 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs375972040 | chr1:84236820-84236821 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs189567240 | chr1:84236846-84236847 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Medulloblastoma | 21979893 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Wilms tumour | 21544195 | CNVD |
Coronary Disease | 20032323 | CNVD |
Prostate cancer | 21965145 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Stargardt''s disease | 17277736 | CNVD |
Neuroblastoma | 17897457 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Cancer | 21637783 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Neuroblastoma | 21484798 | CNVD |
Non-syndromic sensorineural hearing loss | 22290220 | CNVD |
Liposarcoma | 21253554 | CNVD |
Breast cancer | 21264507 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Astrocytoma | 17387387 | CNVD |
Cancer | 21499728 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Papillary thyroid carcinoma | 21436994 | CNVD |
Neuroblastoma | 17535989 | CNVD |
Pheochromocytoma | 17535989 | CNVD |
Prostate cancer | 16705090 | CNVD |
Astrocytoma | 17934521 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Neuroblastoma | 18664255 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Gastrointestinal stromal cancer | 19259404 | CNVD |
Gastrointestinal stromal cancer | 20470368 | CNVD |
Gastrointestinal stromal cancer | 17535989 | CNVD |
Neuroblastoma | 17533364 | CNVD |
Paraganglioma | 17535989 | CNVD |
Pulmonary chondroma | 17535989 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Breast cancer | 17603634 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Schizophrenia | 19415332 | CNVD |
Non-syndromic sensorineural hearing loss | 21030649 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Autism | 22495311 | CNVD |
Non-small cell lung cancer | 21385341 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Chordoma | 21602918 | CNVD |
Acute lymphoblastic leukemia | 17443227 | CNVD |
Melanoma | 18172304 | CNVD |
Multiple myeloma | 16461302 | CNVD |
Cancer | 21129771 | CNVD |
Autosomal dominant nocturnal frontal lobe epilepsy | 18472482 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
Non-small cell lung cancer | 20864512 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Thrombocytopenia-absent radius syndrome | 21933853 | CNVD |
Psychiatric disorder | 22848183 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Breast cancer | 20409316 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Lung cancer | 18438408 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Breast cancer | 17393978 | CNVD |
Cervical cancer | 21062161 | CNVD |
Cancer | 21183584 | CNVD |
Breast cancer | 21785460 | CNVD |
Breast cancer | 21364760 | CNVD |
Rett syndrome | 21593744 | CNVD |
Prostate cancer | 16573809 | CNVD |
Breast cancer | 16608533 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Breast cancer | 17133270 | CNVD |
Type 2 diabetes | 21956041 | CNVD |
Uveal melanoma | 20484589 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Intellectual disability | 22102821 | CNVD |
Cancer | 20164919 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Poland''s syndrome | 22110015 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Glioblastoma multiforme | 21922591 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Cancer | 22429812 | CNVD |
Effusion lymphoma | 18079361 | CNVD |
Non-muscle invasive bladder neoplasm | 19445696 | CNVD |
Malignant mesothelioma | 18160781 | CNVD |
Pleural malignant mesothelioma | 18160781 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Pancreatic endocrine tumor | 17639061 | CNVD |
Breast cancer | 22522925 | CNVD |
Gastrointestinal stromal cancer | 20818650 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Non-syndromic sensorineural hearing loss | 18451855 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr1:84234600-84236200 | Enhancers | Breast Myoepithelial Primary Cells | Breast |
2 | chr1:84234600-84236200 | Enhancers | Primary B cells from peripheral blood | blood |
3 | chr1:84234600-84236400 | Enhancers | Primary B cells from cord blood | blood |
4 | chr1:84234800-84236200 | Enhancers | Fetal Brain Male | brain |
5 | chr1:84234800-84236200 | Active TSS | Pancreatic Islets | Pancreatic Islet |
6 | chr1:84235000-84236400 | Enhancers | Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells | embryonic stem cell |
7 | chr1:84235600-84236200 | Enhancers | Cortex derived primary cultured neurospheres | brain |
8 | chr1:84235800-84236200 | Enhancers | Brain Substantia Nigra | brain |
9 | chr1:84236000-84237200 | Enhancers | Liver | Liver |
10 | chr1:84236400-84237400 | Weak transcription | Primary B cells from cord blood | blood |